Forest and Cypress Announce Submission of New Drug Application for … - FOX News

Click the bright blue link (just below) to read the full news article.


Forest and Cypress Announce Submission of New Drug Application for
FOX News - Dec 31, 2007
Milnacipran is jointly being developed for fibromyalgia syndrome in the United States market by Forest and its licensor, Cypress Bioscience,

Categories: All ME/ Chronic Fatigue Syndrome And Fibromyalgia News, Research

Read Full Post Comment
del.icio.us Digg Furl BlinkList StumbleUpon Technorati

Leave a Comment

Subscribe without commenting